Benzinga | Oct 27, 2021 04:18PM EDT

Edwards Lifesciences Q3 EPS $0.54 Beats $0.53 Estimate, Sales $1.31B Miss $1.32B Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.53 by 1.89 percent. This is a 5.88 percent increase over earnings of $0.51 per share from the same period last year. The company reported quarterly sales of $1.31 billion which missed the analyst consensus estimate of $1.32 billion by 0.76 percent. This is a 14.81 percent increase over sales of $1.14 billion the same period last year.